VolitionRX Limited (VNRX)
(Delayed Data from AMEX)
$0.88 USD
+0.12 (16.21%)
Updated Oct 4, 2024 03:59 PM ET
After-Market: $0.88 0.00 (-0.34%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for VolitionRX Limited falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 1 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 37 | 32 | 28 | 21 | 16 |
Income After Depreciation & Amortization | -36 | -32 | -28 | -21 | -16 |
Non-Operating Income | 1 | 1 | 2 | 1 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -36 | -31 | -27 | -20 | -16 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -36 | -31 | -27 | -20 | -16 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -35 | -30 | -27 | -20 | -16 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -35 | -31 | -27 | -21 | -15 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 1 | 1 | 1 |
Income After Depreciation & Amortization | -36 | -32 | -28 | -21 | -16 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 71.24 | 55.35 | 52.66 | 45.28 | 39.18 |
Diluted EPS Before Non-Recurring Items | -0.50 | -0.55 | -0.51 | -0.45 | -0.41 |
Diluted Net EPS (GAAP) | -0.50 | -0.55 | -0.51 | -0.45 | -0.41 |
Fiscal Year end for VolitionRX Limited falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 0.40 | 0.17 | 0.24 | 0.17 | 0.22 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.40 | 0.17 | 0.24 | 0.17 | 0.22 |
SG&A, R&D, and Dept/Amort Expenses | 7.39 | 8.56 | 8.98 | 8.82 | 9.76 |
Income After SG&A, R&D, and Dept/Amort Expenses | -6.99 | -8.39 | -8.74 | -8.65 | -9.54 |
Non-Operating Income | 0.01 | -0.01 | 0.00 | 0.25 | 0.06 |
Interest Expense | 0.08 | 0.08 | 0.06 | 0.05 | 0.06 |
Pretax Income | -7.06 | -8.47 | -8.80 | -8.45 | -9.55 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | -0.07 | -0.10 | -0.10 | -0.08 | -0.08 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -7.06 | -8.47 | -8.80 | -8.45 | -9.55 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -6.99 | -8.37 | -8.70 | -8.37 | -9.47 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 82.67 | 81.96 | 81.17 | 78.18 | 66.88 |
Diluted EPS Before Non-Recurring Items | -0.08 | -0.10 | -0.11 | -0.11 | -0.14 |
Diluted Net EPS (GAAP) | -0.08 | -0.10 | -0.10 | -0.11 | -0.14 |